A recent study conducted at UKE Hamburg compared manual and software-assisted assessments of computed tomography (CT) scans according to iRECIST (immune Response Evaluation Criteria in Solid Tumors) in oncological patients undergoing immune-based treatment. Utilizing mint Lesion™ for software-assisted assessment, the study found that software-assisted assessments resulted in shorter reading times, lower error rates, and higher inter-reader agreement compared to manual assessments. The researchers thus concluded that software-assisted iRECIST assessments are preferable over manual approaches for optimal oncological response evaluation.
Software-Assisted CT Assessment Outperforms Manual Methods in Oncology Study
Related Resources
Related Resources
MROC: The Impact of mpMRI on the Staging and Management of Patients with Suspected or Confirmed OC
Funded by the National Institute of Health Research (NIHR) and sponsored by the Imperial College London, the MROC study boasts impressive figures: 645…
AI-powered quantification of bone metastasis in prostate cancer
Prostate cancer is the second most common cancer among men, and there are now effective treatments for the disease. New therapies available on the…
Radiomics - the next era of possibilities in Precision Medicine
Traditionally medical image analysis has been done through visual interpretation of static images. In the past decade, with the advent of…